UTHR logo

United Therapeutics (UTHR) Operating profit

annual operating profit:

$1.45B+$263.20M(+22.21%)
December 31, 2024

Summary

  • As of today (May 18, 2025), UTHR annual operating income is $1.45 billion, with the most recent change of +$263.20 million (+22.21%) on December 31, 2024.
  • During the last 3 years, UTHR annual operating profit has risen by +$892.20 million (+160.50%).
  • UTHR annual operating profit is now at all-time high.

Performance

UTHR Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRincome statement metrics

quarterly operating profit:

$382.80M+$19.10M(+5.25%)
March 31, 2025

Summary

  • As of today (May 18, 2025), UTHR quarterly operating income is $382.80 million, with the most recent change of +$19.10 million (+5.25%) on March 31, 2025.
  • Over the past year, UTHR quarterly operating profit has increased by +$26.50 million (+7.44%).
  • UTHR quarterly operating profit is now -6.22% below its all-time high of $408.20 million, reached on September 30, 2024.

Performance

UTHR quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRincome statement metrics

TTM operating profit:

$1.47B+$26.50M(+1.83%)
March 31, 2025

Summary

  • As of today (May 18, 2025), UTHR TTM operating income is $1.47 billion, with the most recent change of +$26.50 million (+1.83%) on March 31, 2025.
  • Over the past year, UTHR TTM operating profit has increased by +$217.80 million (+17.33%).
  • UTHR TTM operating profit is now at all-time high.

Performance

UTHR TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

UTHR Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+22.2%+7.4%+17.3%
3 y3 years+160.5%+32.9%+62.3%
5 y5 years+871.9%+129.6%+132.2%

UTHR Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+160.5%-6.2%+118.0%at high+66.0%
5 y5-yearat high+871.9%-6.2%+690.7%at high+307.2%
alltimeall timeat high+871.9%-6.2%+158.4%at high+886.0%

UTHR Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
$382.80M(+5.3%)
$1.47B(+1.8%)
Dec 2024
$1.45B(+22.2%)
$363.70M(-10.9%)
$1.45B(+7.7%)
Sep 2024
-
$408.20M(+27.6%)
$1.34B(+6.4%)
Jun 2024
-
$319.90M(-10.2%)
$1.26B(+0.5%)
Mar 2024
-
$356.30M(+37.0%)
$1.26B(+6.1%)
Dec 2023
$1.18B(+20.9%)
$260.10M(-20.5%)
$1.18B(+7.7%)
Sep 2023
-
$327.00M(+4.3%)
$1.10B(+1.2%)
Jun 2023
-
$313.40M(+10.2%)
$1.09B(+11.4%)
Mar 2023
-
$284.40M(+62.0%)
$976.10M(-0.4%)
Dec 2022
$979.70M(+76.2%)
$175.60M(-44.1%)
$979.70M(+0.6%)
Sep 2022
-
$314.30M(+55.7%)
$973.90M(+9.6%)
Jun 2022
-
$201.80M(-29.9%)
$888.30M(-2.2%)
Mar 2022
-
$288.00M(+69.6%)
$908.70M(+63.5%)
Dec 2021
$555.90M(-6.4%)
$169.80M(-25.8%)
$555.90M(+23.2%)
Sep 2021
-
$228.70M(+2.9%)
$451.40M(+1.7%)
Jun 2021
-
$222.20M(-442.9%)
$443.80M(+22.6%)
Mar 2021
-
-$64.80M(-199.2%)
$362.10M(-39.0%)
Dec 2020
$593.60M(-416.4%)
$65.30M(-70.5%)
$593.60M(+0.3%)
Sep 2020
-
$221.10M(+57.4%)
$591.80M(+6.8%)
Jun 2020
-
$140.50M(-15.7%)
$554.10M(-12.7%)
Mar 2020
-
$166.70M(+162.5%)
$635.00M(-438.5%)
Dec 2019
-$187.60M(-123.3%)
$63.50M(-65.4%)
-$187.60M(+56.9%)
Sep 2019
-
$183.40M(-17.2%)
-$119.60M(-22.0%)
Jun 2019
-
$221.40M(-133.8%)
-$153.40M(-2.5%)
Mar 2019
-
-$655.90M(-598.8%)
-$157.40M(-119.5%)
Dec 2018
$805.40M(-21.4%)
$131.50M(-12.1%)
$805.40M(-0.9%)
Sep 2018
-
$149.60M(-31.2%)
$812.90M(-17.6%)
Jun 2018
-
$217.40M(-29.2%)
$987.10M(-7.6%)
Mar 2018
-
$306.90M(+120.8%)
$1.07B(+4.2%)
Dec 2017
$1.02B(-3.5%)
$139.00M(-57.1%)
$1.02B(-3.3%)
Sep 2017
-
$323.80M(+8.5%)
$1.06B(+8.7%)
Jun 2017
-
$298.50M(+13.2%)
$974.90M(+1.4%)
Mar 2017
-
$263.60M(+51.3%)
$961.60M(-9.4%)
Dec 2016
$1.06B(+51.9%)
$174.20M(-27.0%)
$1.06B(+1.8%)
Sep 2016
-
$238.60M(-16.3%)
$1.04B(-12.5%)
Jun 2016
-
$285.20M(-21.6%)
$1.19B(+10.5%)
Mar 2016
-
$363.70M(+134.6%)
$1.08B(+54.1%)
Dec 2015
$699.00M(+29.7%)
$155.00M(-59.9%)
$699.00M(-3.3%)
Sep 2015
-
$387.00M(+125.3%)
$722.58M(+138.2%)
Jun 2015
-
$171.80M(-1260.8%)
$303.34M(-1.5%)
Mar 2015
-
-$14.80M(-108.3%)
$307.86M(-42.9%)
Dec 2014
$538.80M(+84.2%)
$178.58M(-654.0%)
$538.80M(+62.4%)
Sep 2014
-
-$32.24M(-118.3%)
$331.73M(-29.2%)
Jun 2014
-
$176.32M(-18.4%)
$468.62M(+13.0%)
Mar 2014
-
$216.14M(-858.6%)
$414.60M(+41.7%)
Dec 2013
$292.50M(-30.6%)
-$28.49M(-127.2%)
$292.50M(-34.9%)
Sep 2013
-
$104.65M(-14.4%)
$449.59M(+5.6%)
Jun 2013
-
$122.30M(+30.1%)
$425.66M(+4.1%)
Mar 2013
-
$94.04M(-26.9%)
$408.95M(-3.0%)
Dec 2012
$421.65M(+32.7%)
$128.60M(+59.3%)
$421.65M(+18.3%)
Sep 2012
-
$80.72M(-23.6%)
$356.55M(-5.9%)
Jun 2012
-
$105.59M(-1.1%)
$378.81M(-2.3%)
Mar 2012
-
$106.74M(+68.1%)
$387.71M(+22.0%)
DateAnnualQuarterlyTTM
Dec 2011
$317.78M(+85.5%)
$63.51M(-38.3%)
$317.78M(+17.9%)
Sep 2011
-
$102.98M(-10.1%)
$269.61M(+17.7%)
Jun 2011
-
$114.49M(+211.1%)
$229.12M(+19.9%)
Mar 2011
-
$36.80M(+140.0%)
$191.11M(+2.4%)
Dec 2010
$171.31M(+558.9%)
$15.33M(-75.5%)
$186.55M(+10.4%)
Sep 2010
-
$62.49M(-18.3%)
$169.03M(+42.9%)
Jun 2010
-
$76.48M(+137.2%)
$118.28M(+213.9%)
Mar 2010
-
$32.25M(-1577.8%)
$37.68M(+44.9%)
Dec 2009
$26.00M(-131.7%)
-$2.18M(-118.6%)
$26.00M(-124.6%)
Sep 2009
-
$11.74M(-384.8%)
-$105.68M(+6.4%)
Jun 2009
-
-$4.12M(-120.0%)
-$99.35M(+30.3%)
Mar 2009
-
$20.57M(-115.4%)
-$76.24M(-7.1%)
Dec 2008
-$82.06M(-1401.9%)
-$133.86M(-841.2%)
-$82.06M(-289.0%)
Sep 2008
-
$18.06M(-4.9%)
$43.41M(+9.9%)
Jun 2008
-
$18.99M(+28.7%)
$39.51M(+38.3%)
Mar 2008
-
$14.75M(-275.7%)
$28.56M(+353.2%)
Dec 2007
$6.30M(-78.3%)
-$8.39M(-159.3%)
$6.30M(-65.5%)
Sep 2007
-
$14.16M(+76.0%)
$18.25M(+17.5%)
Jun 2007
-
$8.04M(-207.2%)
$15.52M(-18.3%)
Mar 2007
-
-$7.50M(-311.5%)
$18.99M(-34.5%)
Dec 2006
$28.98M(-32.4%)
$3.55M(-69.0%)
$28.98M(-19.0%)
Sep 2006
-
$11.43M(-0.7%)
$35.79M(-8.0%)
Jun 2006
-
$11.52M(+363.6%)
$38.89M(+0.9%)
Mar 2006
-
$2.48M(-76.0%)
$38.54M(-10.2%)
Dec 2005
$42.89M(+224.7%)
$10.36M(-28.8%)
$42.89M(+10.4%)
Sep 2005
-
$14.54M(+30.2%)
$38.85M(+29.4%)
Jun 2005
-
$11.16M(+63.2%)
$30.01M(+33.9%)
Mar 2005
-
$6.84M(+8.3%)
$22.42M(+69.7%)
Dec 2004
$13.21M(-214.6%)
$6.31M(+10.8%)
$13.21M(+291.6%)
Sep 2004
-
$5.70M(+59.6%)
$3.37M(-182.9%)
Jun 2004
-
$3.57M(-250.5%)
-$4.07M(-61.1%)
Mar 2004
-
-$2.37M(-32.6%)
-$10.47M(-9.2%)
Dec 2003
-$11.53M(-36.0%)
-$3.52M(+102.1%)
-$11.53M(+3.7%)
Sep 2003
-
-$1.74M(-38.4%)
-$11.12M(-30.1%)
Jun 2003
-
-$2.83M(-17.6%)
-$15.91M(+10.0%)
Mar 2003
-
-$3.43M(+10.2%)
-$14.46M(-19.7%)
Dec 2002
-$18.00M(-61.6%)
-$3.11M(-52.4%)
-$18.00M(-26.2%)
Sep 2002
-
-$6.54M(+374.0%)
-$24.40M(-18.0%)
Jun 2002
-
-$1.38M(-80.2%)
-$29.76M(-28.0%)
Mar 2002
-
-$6.97M(-26.7%)
-$41.36M(-10.6%)
Dec 2001
-$46.94M(-42.4%)
-$9.51M(-20.0%)
-$46.28M(-31.8%)
Sep 2001
-
-$11.90M(-8.3%)
-$67.83M(+2.2%)
Jun 2001
-
-$12.97M(+9.1%)
-$66.36M(-20.9%)
Mar 2001
-
-$11.89M(-61.7%)
-$83.91M(+3.0%)
Dec 2000
-$81.50M(+130.5%)
-$31.07M(+198.1%)
-$81.50M(+36.1%)
Sep 2000
-
-$10.42M(-65.8%)
-$59.89M(+5.9%)
Jun 2000
-
-$30.52M(+221.6%)
-$56.57M(+75.4%)
Mar 2000
-
-$9.49M(+0.3%)
-$32.25M(-8.0%)
Dec 1999
-$35.36M(+165.0%)
-$9.46M(+33.3%)
-$35.06M(+37.0%)
Sep 1999
-
-$7.10M(+14.5%)
-$25.60M(+38.4%)
Jun 1999
-
-$6.20M(-49.6%)
-$18.50M(+50.4%)
Mar 1999
-
-$12.30M
-$12.30M
Dec 1998
-$13.35M
-
-

FAQ

  • What is United Therapeutics annual operating income?
  • What is the all time high annual operating profit for United Therapeutics?
  • What is United Therapeutics annual operating profit year-on-year change?
  • What is United Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for United Therapeutics?
  • What is United Therapeutics quarterly operating profit year-on-year change?
  • What is United Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for United Therapeutics?
  • What is United Therapeutics TTM operating profit year-on-year change?

What is United Therapeutics annual operating income?

The current annual operating profit of UTHR is $1.45B

What is the all time high annual operating profit for United Therapeutics?

United Therapeutics all-time high annual operating income is $1.45B

What is United Therapeutics annual operating profit year-on-year change?

Over the past year, UTHR annual operating income has changed by +$263.20M (+22.21%)

What is United Therapeutics quarterly operating income?

The current quarterly operating profit of UTHR is $382.80M

What is the all time high quarterly operating profit for United Therapeutics?

United Therapeutics all-time high quarterly operating income is $408.20M

What is United Therapeutics quarterly operating profit year-on-year change?

Over the past year, UTHR quarterly operating income has changed by +$26.50M (+7.44%)

What is United Therapeutics TTM operating income?

The current TTM operating profit of UTHR is $1.47B

What is the all time high TTM operating profit for United Therapeutics?

United Therapeutics all-time high TTM operating income is $1.47B

What is United Therapeutics TTM operating profit year-on-year change?

Over the past year, UTHR TTM operating income has changed by +$217.80M (+17.33%)
On this page